Optimizing Digital Tools for the Field of Substance Use and Substance Use Disorders: Backcasting Exercise.

addictions backcasting exercise digital health digital tools drug addiction eHealth ethical frameworks substance use substance use disorders telemedicine

Journal

JMIR human factors
ISSN: 2292-9495
Titre abrégé: JMIR Hum Factors
Pays: Canada
ID NLM: 101666561

Informations de publication

Date de publication:
12 Dec 2023
Historique:
received: 01 03 2023
accepted: 12 08 2023
revised: 14 07 2023
medline: 12 12 2023
pubmed: 12 12 2023
entrez: 12 12 2023
Statut: epublish

Résumé

Substance use trends are complex; they often rapidly evolve and necessitate an intersectional approach in research, service, and policy making. Current and emerging digital tools related to substance use are promising but also create a range of challenges and opportunities. This paper reports on a backcasting exercise aimed at the development of a roadmap that identifies values, challenges, facilitators, and milestones to achieve optimal use of digital tools in the substance use field by 2030. A backcasting exercise method was adopted, wherein the core elements are identifying key values, challenges, facilitators, milestones, cornerstones and a current, desired, and future scenario. A structured approach was used by means of (1) an Open Science Framework page as a web-based collaborative working space and (2) key stakeholders' collaborative engagement during the 2022 Lisbon Addiction Conference. The identified key values were digital rights, evidence-based tools, user-friendliness, accessibility and availability, and person-centeredness. The key challenges identified were ethical funding, regulations, commercialization, best practice models, digital literacy, and access or reach. The key facilitators identified were scientific research, interoperable infrastructure and a culture of innovation, expertise, ethical funding, user-friendly designs, and digital rights and regulations. A range of milestones were identified. The overarching identified cornerstones consisted of creating ethical frameworks, increasing access to digital tools, and continuous trend analysis. The use of digital tools in the field of substance use is linked to a range of risks and opportunities that need to be managed. The current trajectories of the use of such tools are heavily influenced by large multinational for-profit companies with relatively little involvement of key stakeholders such as people who use drugs, service providers, and researchers. The current funding models are problematic and lack the necessary flexibility associated with best practice business approaches such as lean and agile principles to design and execute customer discovery methods. Accessibility and availability, digital rights, user-friendly design, and person-focused approaches should be at the forefront in the further development of digital tools. Global legislative and technical infrastructures by means of a global action plan and strategy are necessary and should include ethical frameworks, accessibility of digital tools for substance use, and continuous trend analysis as cornerstones.

Sections du résumé

BACKGROUND BACKGROUND
Substance use trends are complex; they often rapidly evolve and necessitate an intersectional approach in research, service, and policy making. Current and emerging digital tools related to substance use are promising but also create a range of challenges and opportunities.
OBJECTIVE OBJECTIVE
This paper reports on a backcasting exercise aimed at the development of a roadmap that identifies values, challenges, facilitators, and milestones to achieve optimal use of digital tools in the substance use field by 2030.
METHODS METHODS
A backcasting exercise method was adopted, wherein the core elements are identifying key values, challenges, facilitators, milestones, cornerstones and a current, desired, and future scenario. A structured approach was used by means of (1) an Open Science Framework page as a web-based collaborative working space and (2) key stakeholders' collaborative engagement during the 2022 Lisbon Addiction Conference.
RESULTS RESULTS
The identified key values were digital rights, evidence-based tools, user-friendliness, accessibility and availability, and person-centeredness. The key challenges identified were ethical funding, regulations, commercialization, best practice models, digital literacy, and access or reach. The key facilitators identified were scientific research, interoperable infrastructure and a culture of innovation, expertise, ethical funding, user-friendly designs, and digital rights and regulations. A range of milestones were identified. The overarching identified cornerstones consisted of creating ethical frameworks, increasing access to digital tools, and continuous trend analysis.
CONCLUSIONS CONCLUSIONS
The use of digital tools in the field of substance use is linked to a range of risks and opportunities that need to be managed. The current trajectories of the use of such tools are heavily influenced by large multinational for-profit companies with relatively little involvement of key stakeholders such as people who use drugs, service providers, and researchers. The current funding models are problematic and lack the necessary flexibility associated with best practice business approaches such as lean and agile principles to design and execute customer discovery methods. Accessibility and availability, digital rights, user-friendly design, and person-focused approaches should be at the forefront in the further development of digital tools. Global legislative and technical infrastructures by means of a global action plan and strategy are necessary and should include ethical frameworks, accessibility of digital tools for substance use, and continuous trend analysis as cornerstones.

Identifiants

pubmed: 38085569
pii: v10i1e46678
doi: 10.2196/46678
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e46678

Informations de copyright

©Florian Scheibein, Elsa Caballeria, Md Abu Taher, Sidharth Arya, Angus Bancroft, Lisa Dannatt, Charlotte De Kock, Nazish Idrees Chaudhary, Roberto Perez Gayo, Abhishek Ghosh, Lillian Gelberg, Cees Goos, Rebecca Gordon, Antoni Gual, Penelope Hill, Iga Jeziorska, Eliza Kurcevič, Aleksey Lakhov, Ishwor Maharjan, Silvia Matrai, Nirvana Morgan, Ilias Paraskevopoulos, Zrinka Puharić, Goodman Sibeko, Jan Stola, Marcela Tiburcio, Joseph Tay Wee Teck, Zaza Tsereteli, Hugo López-Pelayo. Originally published in JMIR Human Factors (https://humanfactors.jmir.org), 12.12.2023.

Auteurs

Florian Scheibein (F)

School of Health Sciences, South East Technological University, Waterford, Ireland.

Elsa Caballeria (E)

Health and Addictions Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.

Md Abu Taher (MA)

United Nations Office of Drugs and Crime, Dhaka, Bangladesh.

Sidharth Arya (S)

Institute of Mental Health, Pandit Bhagwat Dayal Sharma University of Health Sciences, Rohtak, India.

Angus Bancroft (A)

School of Social and Political Science, University of Edinburgh, Edinburgh, United Kingdom.

Lisa Dannatt (L)

Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.

Charlotte De Kock (C)

Institute for Social Drug Research, Ghent University, Ghent, Belgium.

Nazish Idrees Chaudhary (NI)

International Grace Rehab, Lahore School of Behavioral Sciences, The University of Lahore, Lahore, Pakistan.

Roberto Perez Gayo (RP)

Correlation European Harm Reduction Network, Amsterdam, Netherlands.

Abhishek Ghosh (A)

Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Lillian Gelberg (L)

Department of Family Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States.

Cees Goos (C)

European Centre for Social Welfare Policy and Research, Vienna, Austria.

Rebecca Gordon (R)

Health and Addictions Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.

Antoni Gual (A)

Health and Addictions Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.

Penelope Hill (P)

The National Centre for Clinical Research on Emerging Drugs, Randwick, Australia.
The National Drug and Alcohol Research Centre, University of New South Wales, Randwick, Australia.
National Drug Research Institute, Curtin University, Melbourne, Australia.

Iga Jeziorska (I)

Correlation European Harm Reduction Network, Amsterdam, Netherlands.
Department of Public Policy, Institute of Social and Political Sciences, Corvinus University of Budapest, Budapest, Hungary.

Eliza Kurcevič (E)

Eurasian Harm Reduction Association, Vilnius, Lithuania.

Aleksey Lakhov (A)

Humanitarian Action Charitable Fund, St Petersburg, Russian Federation.

Ishwor Maharjan (I)

Management Center Innsbruck, Innsbruck, Austria.

Silvia Matrai (S)

Health and Addictions Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.

Nirvana Morgan (N)

Network of Early Career Professionals in Addiction Medicine, Seligenstadt, Germany.

Ilias Paraskevopoulos (I)

Kethea Ithaki, Thessaloniki, Greece.

Zrinka Puharić (Z)

Faculty of Dental Medicine and Health Osijek, Bjelovar University of Applied Sciences, Bjelovar, Croatia.

Goodman Sibeko (G)

Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.

Jan Stola (J)

Youth Organisations for Drug Action, Warsaw, Poland.

Marcela Tiburcio (M)

Head of the Department of Social Sciences in Health, Directorate of Epidemiological and Psychosocial Research, Mexico City, Mexico.

Joseph Tay Wee Teck (J)

DigitAS Project, Population and Behavioural Science, School of Medicine, University of St. Andrews, St Andrews, United Kingdom.

Zaza Tsereteli (Z)

Alcohol and Substance Use Expert Group, Northern Dimension Partnership in Public Health and Social Well-Being, Tallinn, Estonia.

Hugo López-Pelayo (H)

Health and Addictions Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.

Classifications MeSH